Dimensional Fund Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $172K | Sell |
34,053
-1,682,722
| -98% | -$8.51M | ﹤0.01% | 3134 |
|
|
2025
Q1 | $9.09M | Buy |
1,716,775
+8,735
| +0.5% | +$46.2K | ﹤0.01% | 2290 |
|
|
2024
Q4 | $11.5M | Sell |
1,708,040
-9,739
| -0.6% | -$65.8K | ﹤0.01% | 2250 |
|
|
2024
Q3 | $11.3M | Sell |
1,717,779
-202,398
| -11% | -$1.33M | ﹤0.01% | 2249 |
|
|
2024
Q2 | $14.4M | Sell |
1,920,177
-174,823
| -8% | -$1.31M | ﹤0.01% | 2109 |
|
|
2024
Q1 | $20.9M | Sell |
2,095,000
-42,110
| -2% | -$420K | 0.01% | 1959 |
|
|
2023
Q4 | $21.1M | Buy |
2,137,110
+1,291,946
| +153% | +$12.7M | 0.01% | 1959 |
|
|
2023
Q3 | $6.47M | Buy |
845,164
+60,376
| +8% | +$462K | ﹤0.01% | 2443 |
|
|
2023
Q2 | $5.86M | Buy |
784,788
+87,503
| +13% | +$654K | ﹤0.01% | 2468 |
|
|
2023
Q1 | $4.65M | Buy |
697,285
+507,357
| +267% | +$3.38M | ﹤0.01% | 2504 |
|
|
2022
Q4 | $1.46K | Buy |
+189,928
| New | +$1.46K | ﹤0.01% | 2810 |
|